What an inspiring evening of innovation and collaboration! Last Thursday, Eagle IP was honored to once again host the American Intellectual Property Law Association (AIPLA) Women in IP Global Networking Event in Hong Kong, joining forces with hundreds of remarkable women across 40+ global cities.

In the spirit of this year’s theme “Innovation and Collaboration,” we gathered fellow female leaders, innovators, entrepreneurs and IP practitioners to share their amazing career journeys and lessons learnt along the way. We started off the evening with Jennifer Che and Pauli Wong, sharing their paths from scientists that transitioned into an IP career, and what it means to them now to support scientists as IP professionals. We were also privileged to have Dr. Cathy Jim, of RHT Industries Limited, share with us her inspiring journey as a Chemist and Entrepreneur. Cathy recounted how she and her team overcame many difficulties along their path to providing a better solution to real world air quality problems through science. Her one piece of advice and guiding principle? Resilience. At 8PM HKT, we promptly dialed into a joint video call to say hello to hundreds of women at 40+ participating cities around the world holding their own simultaneous events.

To all who joined us: thank you for your lively participation and sharing. Together, we’re not just shaping the future of innovation—we’re redefining what it means to lead. Here’s to many more years of collaboration, growth, and breaking barriers!

我们的过去活动

Recommended Insights

How to Protect a Crystal Form (Polymorph) Patent in China

2025年6月4日
Crystalline forms are critical to pharmaceutical patents, offering extended protection for improved stability, bioavailability, or manufacturability. However, securing such patents in China has grown increasingly difficult due to the China National Intellectual Property Administration (CNIPA)’s strict patentability criteria. Unlike the U.S. or Europe, where structural novelty or problem-solving utility may suffice, China demands quantifiable evidence of […]

China’s Newest Examination Guidelines: Inventive Step for Biological / Life Science Inventions (Part III)

2021年4月30日
This is Part III of a three-part series summarizing the Examination Guidelines that were released by the CNIPA on January 15, 2021, one year to the date of Phase 1 of the US and China Economic and Trade Agreement. That agreement included specific provisions where China "shall permit pharmaceutical patent applicants to rely on supplemental […]

Introducing the New USPTO Cancer Moonshot Expedited Examination Pilot Program

2023年1月10日
Starting from February 1, 2023, the USPTO will begin the new Cancer Moonshot Expedited Examination Pilot Program that advances out-of-turn applications that are directed to oncology or smoking cessation. This new program will replace the Cancer Immunotherapy Pilot Program that has been in place since 2016, and covers more technologies than only cancer immunotherapies. Applications […]

Hong Kong Launches New Original Grant Patent System

2019年12月17日
Hong Kong will be launching a new patent system on December 19, 2019 that includes key changes, most notably the introduction of an original grant patent system. This new patent system includes both the Patents (Amendment) Ordinance 2016 and the Patents (General) (Amendment) Rules 2019. Currently, there are two types of patent applications available in […]
Top crossarrow-right